UTI shares fell after the Company projected fiscal 2027 diluted EPS of just $0.00 to $0.09 while planning approximately $35 million in growth-related investments, subject to regulatory approvals.
NEW YORK, Nov. 20, 2026 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE: UTI) shares fell after the Company's fiscal fourth-quarter 2026 report projected fiscal 2027 diluted EPS of just $0.00 to $0.09, down from $0.60 in fiscal 2026, while anticipating approximately $35 million in EBITDA impact from planned campus openings and program expansions subject to regulatory approvals. If you bought UTI shares and are now holding a loss, you are encouraged to submit your UTI loss for review right away. You may also contact Joseph E. Levi, Esq. at [email protected] or by telephone at (888) SueWallSt.
UTI's SEC filings have disclosed regulatory approval requirements tied to new campuses and programs. On November 19, 2025, CFO Bruce Schuman addressed federal student-verification backlogs at the U.S. Department of Education, assuring investors: "We've seen no impact at all on the front end."
One year later, management projected fiscal 2027 diluted EPS of just $0.00 to $0.09, while anticipating approximately $35 million in EBITDA impact from planned campus openings, program launches, and capacity expansions, all subject to regulatory approvals. At the midpoint of $0.045 per share, projected earnings represented approximately one-thirteenth of fiscal 2026 diluted EPS of $0.60.
Down on UTI? Tell us about your losses today or call Joseph E. Levi, Esq. at (888) SueWallSt.
WHY SUEWALLST : SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured billions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Frequently Asked Questions About the UTI Investigation
Q: Who is eligible to participate in the UTI investigation? A: Investors who purchased UTI stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Universal Technical Institute made materially false or misleading statements regarding regulatory and operational risks associated with its campus and program expansion, as well as federal student-aid verification requirements. The investigation also examines whether the Company adequately disclosed risks that could affect its growth plans and financial outlook. Following the Company's announcement of fiscal 2027 diluted EPS guidance of just $0.00 to $0.09, UTI shares declined.
Q: What do UTI investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation.
Q: What is a lead plaintiff and why does it matter? A: If the investigation proceeds to legal action, a lead plaintiff is the investor the court appoints to represent the group of affected investors. Lead plaintiffs are typically investors with the largest documented losses. Contacting the firm during the investigation phase preserves that option.
Q: What if I already sold my UTI shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought UTI and sold at a loss may still participate in the investigation.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
Tel: (888) SueWallSt
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
SOURCE SueWallSt.com

Share this article